These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36421256)

  • 1. Effect of Glycerol on Fosfomycin Activity against
    Ortiz-Padilla M; Portillo-Calderón I; Velázquez-Escudero A; Rodríguez-Baño J; Pascual Á; Rodríguez-Martínez JM; Docobo-Pérez F
    Antibiotics (Basel); 2022 Nov; 11(11):. PubMed ID: 36421256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular insights into fosfomycin resistance in Escherichia coli.
    Ballestero-Téllez M; Docobo-Pérez F; Portillo-Calderón I; Rodríguez-Martínez JM; Racero L; Ramos-Guelfo MS; Blázquez J; Rodríguez-Baño J; Pascual A
    J Antimicrob Chemother; 2017 May; 72(5):1303-1309. PubMed ID: 28093485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated Expression of GlpT and UhpT via FNR Activation Contributes to Increased Fosfomycin Susceptibility in Escherichia coli under Anaerobic Conditions.
    Kurabayashi K; Tanimoto K; Fueki S; Tomita H; Hirakawa H
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6352-60. PubMed ID: 26248376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of fosfomycin with the glycerol 3-phosphate transporter of Escherichia coli.
    Santoro A; Cappello AR; Madeo M; Martello E; Iacopetta D; Dolce V
    Biochim Biophys Acta; 2011 Dec; 1810(12):1323-9. PubMed ID: 21791237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The glycerol-3-phosphate permease GlpT is the only fosfomycin transporter in Pseudomonas aeruginosa.
    Castañeda-García A; Rodríguez-Rojas A; Guelfo JR; Blázquez J
    J Bacteriol; 2009 Nov; 191(22):6968-74. PubMed ID: 19734311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations of the Transporter Proteins GlpT and UhpT Confer Fosfomycin Resistance in
    Xu S; Fu Z; Zhou Y; Liu Y; Xu X; Wang M
    Front Microbiol; 2017; 8():914. PubMed ID: 28579984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of inorganic phosphate concentrations in in vitro activity of fosfomycin.
    Ortiz-Padilla M; Portillo-Calderón I; Maldonado N; Rodríguez-Martínez J; de Gregorio-Iaria B; Merino-Bohórquez V; Rodríguez-Baño J; Pascual Á; Docobo-Pérez F
    Clin Microbiol Infect; 2022 Feb; 28(2):302.e1-302.e4. PubMed ID: 34634457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency and Mechanisms of Spontaneous Fosfomycin Nonsusceptibility Observed upon Disk Diffusion Testing of Escherichia coli.
    Lucas AE; Ito R; Mustapha MM; McElheny CL; Mettus RT; Bowler SL; Kantz SF; Pacey MP; Pasculle AW; Cooper VS; Doi Y
    J Clin Microbiol; 2018 Jan; 56(1):. PubMed ID: 29093108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of Low-Level Fosfomycin-Resistant Variants by Decreasing Glucose-6-Phosphate Concentration in Fosfomycin Susceptibility Determination.
    Martín-Gutiérrez G; Docobo-Pérez F; Rodríguez-Martínez JM; Pascual A; Blázquez J; Rodriguez-Beltrán J
    Antibiotics (Basel); 2020 Nov; 9(11):. PubMed ID: 33198311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms of fosfomycin resistance in clinical isolates of Escherichia coli.
    Takahata S; Ida T; Hiraishi T; Sakakibara S; Maebashi K; Terada S; Muratani T; Matsumoto T; Nakahama C; Tomono K
    Int J Antimicrob Agents; 2010 Apr; 35(4):333-7. PubMed ID: 20071153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cooperative Actions of CRP-cAMP and FNR Increase the Fosfomycin Susceptibility of Enterohaemorrhagic
    Kurabayashi K; Tanimoto K; Tomita H; Hirakawa H
    Front Microbiol; 2017; 8():426. PubMed ID: 28360903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial Susceptibility and Molecular Mechanisms of Fosfomycin Resistance in Clinical Escherichia coli Isolates in Mainland China.
    Li Y; Zheng B; Li Y; Zhu S; Xue F; Liu J
    PLoS One; 2015; 10(8):e0135269. PubMed ID: 26252888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of fosfomycin resistance and gene mutations in clinical isolates of methicillin-resistant Staphylococcus aureus.
    Lee YC; Chen PY; Wang JT; Chang SC
    Antimicrob Resist Infect Control; 2020 Aug; 9(1):135. PubMed ID: 32807239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of inoculum and mutant frequency on fosfomycin MIC discrepancies by agar dilution and broth microdilution methods in Enterobacteriaceae.
    Ballestero-Téllez M; Docobo-Pérez F; Rodríguez-Martínez JM; Conejo MC; Ramos-Guelfo MS; Blázquez J; Rodríguez-Baño J; Pascual A
    Clin Microbiol Infect; 2017 May; 23(5):325-331. PubMed ID: 28062317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of Four Fosfomycin Susceptibility Testing Methods against an International Collection of Clinical Pseudomonas aeruginosa Isolates.
    Smith EC; Brigman HV; Anderson JC; Emery CL; Bias TE; Bergen PJ; Landersdorfer CB; Hirsch EB
    J Clin Microbiol; 2020 Sep; 58(10):. PubMed ID: 32669380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxygen Limitation Enhances the Antimicrobial Activity of Fosfomycin in
    Hirakawa H; Kurabayashi K; Tanimoto K; Tomita H
    Front Microbiol; 2018; 9():1950. PubMed ID: 30186264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of fosfomycin and amikacin against fosfomycin-heteroresistant
    Portillo-Calderón I; Ortiz-Padilla M; de Gregorio-Iaria B; Merino-Bohorquez V; Blázquez J; Rodríguez-Baño J; Rodríguez-Martínez JM; Pascual A; Docobo-Pérez F
    Antimicrob Agents Chemother; 2023 May; 65(5):. PubMed ID: 33685903
    [No Abstract]   [Full Text] [Related]  

  • 18. Antimicrobial susceptibilities of urinary extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae to fosfomycin and nitrofurantoin in a teaching hospital in Taiwan.
    Liu HY; Lin HC; Lin YC; Yu SH; Wu WH; Lee YJ
    J Microbiol Immunol Infect; 2011 Oct; 44(5):364-8. PubMed ID: 21524974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of the combination of colistin and fosfomycin against NDM-1-producing Escherichia coli with variable levels of susceptibility to colistin and fosfomycin in a murine model of peritonitis.
    Le Menestrel A; Guerin F; Chau F; Massias L; Benchetrit L; Cattoir V; Fantin B; de Lastours V
    J Antimicrob Chemother; 2021 Dec; 77(1):155-163. PubMed ID: 34718597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of hypermutation to fosfomycin heteroresistance in Escherichia coli.
    Portillo-Calderón I; Ortiz-Padilla M; Rodríguez-Martínez JM; de Gregorio-Iaria B; Blázquez J; Rodríguez-Baño J; Pascual A; Docobo-Pérez F
    J Antimicrob Chemother; 2020 Aug; 75(8):2066-2075. PubMed ID: 32443144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.